G1 Therapeutics Inc (GTHX)
4.485
+0.04
(+1.01%)
USD |
NASDAQ |
May 03, 16:00
4.58
+0.10
(+2.12%)
After-Hours: 20:00
G1 Therapeutics Profit Margin (Quarterly): -73.14% for Dec. 31, 2023
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | -73.14% |
| September 30, 2023 | -148.0% |
| June 30, 2023 | 20.55% |
| March 31, 2023 | -213.2% |
| December 31, 2022 | -328.3% |
| September 30, 2022 | -107.2% |
| June 30, 2022 | -373.1% |
| March 31, 2022 | -712.7% |
| Date | Value |
|---|---|
| December 31, 2021 | -690.5% |
| September 30, 2021 | -874.2% |
| June 30, 2021 | -596.9% |
| March 31, 2021 | -186.0% |
| December 31, 2020 | -153.2% |
| September 30, 2020 | -43.89% |
| June 30, 2020 | -1.46K% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
-1.46K%
Minimum
Jun 2020
20.55%
Maximum
Jun 2023
-395.9%
Average
-213.2%
Median
Mar 2023
Profit Margin (Quarterly) Benchmarks
| Amicus Therapeutics Inc | -29.41% |
| Geron Corp | -226.0K% |
| Palatin Technologies Inc | -385.6% |
| Oragenics Inc | -- |
| TG Therapeutics Inc | -32.79% |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | -96.05% |
| Return on Assets | -31.87% |
| Return on Invested Capital | -42.99% |
| Gross Profit Margin (Quarterly) | 91.56% |
| Operating Margin (Quarterly) | -60.04% |
| Return on Net Operating Assets | -140.0% |